Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Coronavirus
Good News: Two-Third Indians Have Developed COVID Antibodies, Says Sero Survey
New Delhi: The latest national sero survey has reported good news and sounded a warning as well.
Over two-third Indians (67.6%) have developed antibodies against COVID-19, the fourth such survey by the Indian Council of Medical Research…
Be Careful For 1-2 Years, Don’t Let COVID Explode Again: Warns AIIMS Doctor
New Delhi: People should be careful for the next one to two years and not give a chance to the coronavirus disease (COVID-19) to explode again. Dr Neeraj Nischal, professor at the Medicine Department of AIIMS gave this advice ahead of the…
COVID-19 Delta Variant 40-60 Per Cent More Transmissible Than Alpha, Says Expert
New Delhi: The COVID-19 Delta variant, which first emerged in Maharashtra and travelled northwards along with the western states of the country before entering the central and the eastern states, is around 40-60 per cent more transmissible…
PM Modi Hails Over 40 Crore ‘Bahubali’ In Country
New Delhi: Drawing a witty parallel, Prime Minister Narendra Modi dubbed the people vaccinated against COVID-19 as ‘Bahubali”.
“Vaccine is given in the ‘bahu’ (arms) and those who take it become ‘Bahubali’. So far more than 40 crore people…
COVID: NITI Aayog Sounds Warning Bell, Says Next 100-125 Days Critical
New Delhi: The government said on Friday that the next 100-125 days are critical in the fight against COVID-19.
“Fall in cases has slowed down. It’s a warning signal. Next 100 to 125 days are critical for fight against Covid in India,”…
2 Vaccine Doses Gave 95% Protection From Death: ICMR Study
New Delhi: A large-scale, real-life study conducted by Indian Council of Medical Research (ICMR) has found that two doses of COVID-19 vaccine – be it Covishield or Covaxin -- ensured 95 per cent protection from death.
ICMR conducted the…
COVID Vaccine Trial On Children Near Completion: Centre To Delhi HC
New Delhi: The Centre on Friday told the Delhi High Court that the ongoing trials of COVID-19 vaccines for those aged below 18 years are about to be completed.
The submission was made in a petition filed by a 12-year-old through her mother…
Possibility of Third COVID Wave: Waning Immunity & More Transmissable Variant Could Be Reasons,…
New Delhi: There is a possibility of a third wave of COVID-19 due to waning immunity, the emergence of a more transmissible coronavirus variant capable of escaping the immunity shield and lockdown relaxations, AIIMS Director Randeep Guleria…
Gap Between Two Doses Of Covishield Will Not Be Reduced, Says Delhi HC
New Delhi: The gap between two doses of Covishield vaccines will not be reduced. Delhi High Court on Thursday refused to entertain a plea seeking reduction of the 12-16 week interval for the second dose of Covishield vaccine to eight weeks…
What Are Kappa & Lambda Variants? Should We Fear Them?
New Delhi: Kappa and Lambda have emerged as two new variants of concern along with Delta and Delta Plus.
On 9 July, the Uttar Pradesh government reported two cases of the Kappa variant of the virus in the state, while Lambda), first…